Wasman Jane — SEC Form 4 filings
SEC reporting owner CIK 1352455. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-19.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-25 to 2026-05-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,000 shares, $33,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 20,000 shares @ $1.69 ($33,800) in SELLAS Life Sciences Group, Inc., filed 2025-06-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | Director | 4 | 1 leg · 20,000 sh · $33,800 | — | 5 |
| RIGEL PHARMACEUTICALS INC (RIGL) | Director | 3 | — | — | 5 |
Form 4 filings — Wasman Jane
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 5,750 @ $0 | EDGAR |
| 2026-01-09 | 4 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-06-02 | 4 | SELLAS Life Sciences Group, Inc. (SLS) | Purchase (P): 20,000 @ $1.69 | EDGAR |
| 2025-05-28 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 2,500 @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/award (A): 6,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1352455 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →